UBS Maintains a 'Neutral' on Kemet (KEM); Lowers Estimates on Softer Data Points

UBS maintains a 'Neutral' on Kemet (NYSE: KEM), but slashes price target from $16 to $9.50.

UBS analyst says, "Given the leverage in the model (UBSe 50% incr. GM), we foresee FY12/FY13 Revs/EPS of $1b/$1.50, $1b/$1.56 vs. $1.08b/$2.01, $1.12b/$2.12, prev. Our CY12E EPS goes to $1.34 from $2.05 prev. A less severe macro environment, better pricing, and higher restructuring savings from F&E, could yield upside to our estimates. The stock appears cheap on several metrics but earnings visibility is limited."

For more ratings news on Kemet click here and for the rating history of Kemet click here.

Shares of Kemet closed at $8.52 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• UBS Downgrades Vicinity Centers (VCX:AU) (CNRAF) to Neutral
• UBS Reiterates Buy Rating on Dutch Bros Inc. (BROS): 'One of Strongest Growth Stories in Restaurants'
• JPMorgan Downgrades Rockwool (ROCKB:DC) (RKWBF) to Neutral